血小板通过急性心肌梗塞后的原受体GPVI调节心脏重塑
Friedrich Reusswig1, Matthias Dille1, E Krüger1
1Department of Vascular- and Endovascular Surgery, University Hospital Düsseldorf, Heinrich-Heine University, Düsseldorf, Germany.
Frontiers in immunology
|January 26, 2024
概括
在小鼠中,糖蛋白VI (GPVI) 缺乏改善了心肌梗塞后的心脏重塑,通过减少血小板激活和改变痕原蛋白. 这表明GPVI是改善心脏愈合后缺血性再注射损伤的治疗目标.
科学领域:
- 心血管生物学 心血管生物学
- 血小板生理学 血小板生理学
- 免疫学 免疫学 免疫学
背景情况:
- 血小板在心血管疾病中至关重要,心肌梗塞后活化增强.
- 血小板糖蛋白VI (GPVI) 是一个关键的原受体,参与血小板激活和血栓稳定.
- 以前的研究表明GPVI在炎症和心脏病发作减小中的作用,但其在心脏重塑中的确切功能仍不清楚.
研究的目的:
- 研究GPVI在试验性急性心肌梗塞 (AMI) 后心脏重塑和功能中的作用.
- 为了确定GPVI缺乏是否影响炎症,前凝活动和AMI后痕形成.
主要方法:
- 在实验性AMI的闭胸模型中利用了缺乏GPVI的小鼠.
- 分析了炎症反应,通过GPVI和PAR4受体刺激激活血小板,以及促凝剂活性.
- 在AMI后7天评估与心脏重塑相关的TGF-β和基因表达的血水平 (Col1a1,Col3a1,皮奥斯,Cthrc1).
- 在AMI后21天评估痕原质量和心脏功能.
主要成果:
- 在实验性AMI中,GPVI缺乏没有显著影响炎症反应.
- 在GPVI缺乏的小鼠中,血小板激活的减少导致前凝剂活性降低.
- 由于GPVI缺乏,血TGF-β水平降低,心脏重塑基因的表达发生改变.
- 痕原蛋白质量有所改善,以更紧,更少细原蛋白为特征,导致GPVI缺乏的小鼠心脏功能得到改善.
结论:
- 鉴定GPVI是血小板诱导的心脏改造后AMI的重要调节者.
- 向GPVI可能提供一种治疗策略,以减轻缺血再注射损伤并促进心脏愈合.
更多相关视频
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
12.0K
09:29An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
Published on: July 14, 2023
810
相关概念视频
Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K
